Trademarkia Logo

Canada

C$
TELZYMBIO
APPROVED

on 10 Jun 2025

Last Applicant/ Owned by

IO Biotech ApS

Ole Maaløes Vej 3DK-2200 Copenhagen N

DK

Serial Number

2290504 filed on 20th Sept 2023

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

TELZYMBIO

Trademark usage description

pharmaceutical preparations for the prevention and treatment of musculoskeletal, cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hep Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of musculoskeletal, cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, and dermatological diseases; pharmaceutical drugs and pharmaceutical substances for the prevention and treatment of musculoskeletal, cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, and dermatological diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of musculoskeletal, cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, and dermatological diseases; human vaccines.


Classification kind code

12

Mark Details


Serial Number

2290504

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 27th Jan 2025
Search Recorded
Submitted for opposition 20
on 27th Jan 2025
Examiner's First Report
Submitted for opposition 67
on 27th Sept 2024
Agent Name Changed
Submitted for opposition 256
on 3rd Sept 2024
Notification of Possible Opposition Sent
Submitted for opposition 48
on 29th Nov 2023
Agent Changed
Submitted for opposition 257
on 2th Nov 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 1st Nov 2023
Created
Submitted for opposition 31
on 1st Nov 2023
Formalized
Submitted for opposition 30
on 20th Sept 2023
Filed
Submitted for opposition 228
on 20th Sept 2023
International Registration